Pantoprazole Viatris (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazole Viatris, is a proton pump inhibitor (PPi) presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazole Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole Viatris is a proton pump inhibitor that acts on gastric acid secretion pathways. - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive duodenal ulcer: accelerates ulcer healing and reduces risk of recurrence. - Erosive gastric ulcer: promotes ulcer resolution and decreases acid‑related discomfort.

Pantoprazole is generally well tolerated, but adverse reactions may occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile‑associated colitis: may present with watery diarrhoea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Bone fracture risk with long‑term use: especially in elderly patients. - Liver enzyme elevation: monitor hepatic function if therapy is prolonged.

Before initiating Pantoprazole therapy, consider the following precautions. - Assess renal function: dose adjustment may be required in severe impairment. - Evaluate for hepatitis B/C: risk of reactivation during prolonged therapy. - Monitor magnesium levels: especially in patients on diuretics or long‑term treatment. - Use cautiously in pregnancy: only if clearly needed after risk‑benefit assessment. - Avoid in known hypersensitivity to pantoprazole or other PPIs. - Store at below 25°C: keep in the original container, protect from moisture and light.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (ritonavir, atazanavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation parameters. - Methotrexate: reduced renal clearance may raise toxicity risk. - Clopidogrel: possible reduction in antiplatelet effect. - Digoxin: slight increase in serum levels; observe for toxicity.